Reply to: "Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia-The SPASTOX Trial"

Mov Disord. 2021 Jul;36(7):1734-1735. doi: 10.1002/mds.28658.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Botulinum Toxins, Type A*
  • Humans
  • Muscle Spasticity
  • Spastic Paraplegia, Hereditary* / drug therapy
  • Spastic Paraplegia, Hereditary* / genetics

Substances

  • Botulinum Toxins, Type A